Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial meningitis. Practical guidelines for management

J Rockowitz1, A R Tunkel

  • 1Division of Infectious Diseases, Medical College of Pennsylvania, Philadelphia, USA.

Drugs
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2013
Same author

Antibacterial agents in infections of the central nervous system.

Infectious disease clinics of North America·2000
Same author

Issues in the management of bacterial meningitis.

American family physician·1997
Same author

Acute bacterial meningitis in adults.

Current clinical topics in infectious diseases·1996
Same author

Acute bacterial meningitis.

Lancet (London, England)·1995
Same author

Antibacterial agents in infections of the central nervous system and eye.

Infectious disease clinics of North America·1995
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Bacterial meningitis treatment has advanced from early antiserum to modern antibiotics and vaccines. Evolving antimicrobial strategies and prophylaxis combat resistant pathogens like Streptococcus pneumoniae and Haemophilus influenzae.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Bacterial meningitis therapy has evolved significantly over the last century.
  • Early treatments included antimeningococcal antiserum, followed by sulphonamides and other antibiotics.
  • Understanding pathophysiology led to prophylaxis and adjunctive therapies for sequelae.

Purpose of the Study:

  • To outline principles for selecting appropriate antimicrobial agents for bacterial meningitis.
  • To discuss the impact of antimicrobial resistance on treatment regimens.
  • To review the role of adjunctive therapies, including steroids and vaccines.

Main Methods:

  • Review of historical and current therapeutic approaches for bacterial meningitis.
  • Analysis of antimicrobial resistance patterns, particularly for Streptococcus pneumoniae and Haemophilus influenzae.

Related Experiment Videos

  • Evaluation of adjunctive treatments like steroids and vaccines.

    • Main Results:

    • Third-generation cephalosporins have improved survival rates for Gram-negative bacillary meningitis.
    • Adjunctive steroid use in pediatric meningitis is reconsidered due to vaccine efficacy and effects on drug penetration.
    • Effective chemoprophylaxis and vaccination reduce the spread of H. influenzae and Neisseria meningitidis.

    Conclusions:

    • Antimicrobial selection must account for emerging resistance.
    • Vaccination (e.g., H. influenzae type b conjugate vaccine) is crucial for prevention.
    • Strategic use of prophylaxis and adjunctive therapies enhances patient outcomes.